Abstract
Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(βD-ribofuranosyl) benzimidazole (BDCRB) were synthesized and evaluated for their affinity for hPEPT1, an intestinal oligopeptide transporter. Assays of competitive inhibition of [3H]glycylsarcosine (Gly-Sar) uptake in HeLa/ hPEPT1 cells by the amino acid ester prodrugs of BDCRB suggested their 2- to 4-fold higher affinity for hPEPT1 compared to BDCRB. Further, promoieties with hydrophobic side chains and L-configuration were preferred by the hPEPT1 transporter.
Original language | English (US) |
---|---|
Pages (from-to) | 1274-1277 |
Number of pages | 4 |
Journal | Journal of Medicinal Chemistry |
Volume | 48 |
Issue number | 4 |
DOIs | |
State | Published - Feb 24 2005 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery